Evidence for the gut microbiota short-chain fatty acids as key pathophysiological molecules improving diabetes.
about
Inflammation Meets Metabolic Disease: Gut Feeling Mediated by GLP-1Gut microbiota and liver diseasesExercise-induced stress behavior, gut-microbiota-brain axis and diet: a systematic review for athletesThe dormant blood microbiome in chronic, inflammatory diseases.Potential role of the intestinal microbiota in programming health and disease.Significant differences in fecal microbiota are associated with various stages of glucose tolerance in African American male veterans.Weight and Glucose Reduction Observed with a Combination of Nutritional Agents in Rodent Models Does Not Translate to Humans in a Randomized Clinical Trial with Healthy Volunteers and Subjects with Type 2 Diabetes.Diabetes Mellitus and Increased Tuberculosis Susceptibility: The Role of Short-Chain Fatty Acids.Understanding the Impact of Omega-3 Rich Diet on the Gut Microbiota.New-found link between microbiota and obesity.Free fatty acid G-protein coupled receptor signaling in M1 skewed white adipose tissue macrophages.Production of a mouse strain with impaired glucose tolerance by systemic heterozygous knockout of the glucokinase gene and its feasibility as a prediabetes model.Gut microbiota in renal physiology: focus on short-chain fatty acids and their receptors.Microbiome, inflammation, epigenetic alterations, and mental diseases.More than just a gut feeling: constraint-based genome-scale metabolic models for predicting functions of human intestinal microbes.Thermoneutral housing exacerbates nonalcoholic fatty liver disease in mice and allows for sex-independent disease modeling.Fructooligosaccharide (FOS) and Galactooligosaccharide (GOS) Increase Bifidobacterium but Reduce Butyrate Producing Bacteria with Adverse Glycemic Metabolism in healthy young population.Analysis of the gut microbiome and plasma short-chain fatty acid profiles in a spontaneous mouse model of metabolic syndrome.Feeding of the water extract from Ganoderma lingzhi to rats modulates secondary bile acids, intestinal microflora, mucins, and propionate important to colon cancer.Inflammatory Stress Effects on Health and Function After Spinal Cord Injury.Short-chain fatty acids: a link between prebiotics and microbiota in chronic kidney disease.Remote Sensing between Liver and Intestine: Importance of Microbial Metabolites.Elevated circulating levels of succinate in human obesity are linked to specific gut microbiota.Effect of multi-strain probiotics (multi-strain microbial cell preparation) on glycemic control and other diabetes-related outcomes in people with type 2 diabetes: a randomized controlled trial.A comparative study of the antidiabetic effects exerted by live and dead multi-strain probiotics in the type 2 diabetes model of mice.Differential Microbial Communities of Omnivorous and Herbivorous Cattle in Southern China.Oral administration of short chain fatty acids could attenuate fat deposition of pigs.The Impact of Carnitine on Dietary Fiber and Gut Bacteria Metabolism and Their Mutual Interaction in Monogastrics.The Anti-inflammatory Effects of Short Chain Fatty Acids on Lipopolysaccharide- or Tumor Necrosis Factor α-Stimulated Endothelial Cells via Activation of GPR41/43 and Inhibition of HDACs.
P2860
Q26752511-F1B6E3F0-6AE8-4E2B-8707-5F76DA04DADAQ27015127-02F9723F-52DA-4C28-B2BD-FFEBD1B894F7Q28071822-128AEFFD-F028-456B-B0C0-435DF477DA5EQ34474989-A6040992-D9FC-4C21-AD6C-8800AE668869Q35691572-038D6D17-2D46-4574-BD52-734B7DB2F9EEQ35713388-B44D498A-86DF-430E-B6AE-7F9C171C1955Q35993830-8FEDE543-44C6-49FD-8BE1-E8BE45BE2C20Q36453623-152D62FA-E1D9-4F80-B4AA-3F0A3B012A41Q36731532-373C2728-39C8-40CC-9DE8-B8AB94025440Q38645793-9D60EA54-7542-47A3-A1E8-C3B6CC79A7F5Q38833053-70051FEC-2BEB-4E8C-A1A8-79AF860DB496Q38900637-578569B7-861E-494D-ABFA-D471145B3784Q38941009-FB34BBE0-C6A7-41B4-A61C-CB0F43F3E567Q39425413-F4B4E677-92E8-4BAE-BFA1-BF01360A6666Q39433303-5AADAED3-2CB0-4543-892C-3EB64176ABB3Q40176500-53325CD9-E9CB-40C7-9DFD-8578DE3A6E9FQ41717735-C06667F4-B3EE-4ED7-8B2E-68C6522BBD6EQ46257613-EC9077C6-8C59-4EEB-A07C-B6C367EA649EQ46342898-FC446DE4-F74E-4C5A-9A85-D674F5104597Q47653990-C29C6339-F28E-4C70-81E0-908495117CB9Q47899492-0DD696D9-E1A7-4B0B-A41C-B5D96CAD3A09Q49569061-4343D302-F1FD-4772-8982-1418DE15B817Q50055281-A59EE8CE-5BCC-4142-B926-399D03418C91Q50224848-00A93F76-6B0B-4CE7-BDC8-6EEB53D9051CQ51276608-63D3E34B-28AE-4615-8F0E-D6660AA7C23FQ52568266-97864441-EF34-4B90-8050-41061526BED5Q55086483-7C0C5235-708B-4DFE-9213-2319E3DCD7A1Q55208662-6A8A46E5-148E-4C02-A8C8-6B728B6AFE8CQ55347800-B49EF4C2-8916-4E94-8527-52258FA093F8
P2860
Evidence for the gut microbiota short-chain fatty acids as key pathophysiological molecules improving diabetes.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Evidence for the gut microbiot ...... molecules improving diabetes.
@ast
Evidence for the gut microbiot ...... molecules improving diabetes.
@en
Evidence for the gut microbiot ...... molecules improving diabetes.
@nl
type
label
Evidence for the gut microbiot ...... molecules improving diabetes.
@ast
Evidence for the gut microbiot ...... molecules improving diabetes.
@en
Evidence for the gut microbiot ...... molecules improving diabetes.
@nl
prefLabel
Evidence for the gut microbiot ...... molecules improving diabetes.
@ast
Evidence for the gut microbiot ...... molecules improving diabetes.
@en
Evidence for the gut microbiot ...... molecules improving diabetes.
@nl
P2860
P50
P921
P356
P1476
Evidence for the gut microbiot ...... molecules improving diabetes.
@en
P2860
P304
P356
10.1155/2014/162021
P577
2014-08-17T00:00:00Z